Search Results
Jul 30, 2026, 16:17 ET Cohen & Steers, Inc. Declares Quarterly Dividend
YORK, July 30, 2026 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the third quarter of 2026 in the amount of $0.67 per share of common stock payable on August 20, 2026 to stockholders of record as of the
More news about: Cohen & Steers, Inc.
Jul 30, 2026, 16:17 ET Federated Hermes, Inc. reports record assets under management with second quarter 2026 earnings
Cash and other investments$ 480,710
More news about: Federated Hermes, Inc.
Jul 30, 2026, 16:15 ET LIVE NATION ENTERTAINMENT REPORTS SECOND QUARTER 2026 RESULTS
companies.Free Cash is a non-GAAP financial measure that we define as cash and cash equivalents less ticketing-related client funds, less event-related deferred revenue, less accrued expenses due to artists and cash collected on behalf of others, plus event-related prepaids. We use free cash as a proxy
More news about: Live Nation Entertainment
Jul 30, 2026, 16:15 ET DXC Technology Reports First Quarter Fiscal Year 2027 Results
down 41.2% year-over-year.Cash generated from operations was $418 million, up 124.7% year-over-year. Free cash flow(4) was $314 million, compared to $97 million in the first quarter of fiscal year 2026. Free cash flow in fiscal 2027 includes cash proceeds of $214 million related to
More news about: DXC Technology Company
Jul 30, 2026, 16:15 ET Huntsman Announces Second Quarter 2026 Earnings
million in the prior year period.Second quarter 2026 net cash used in operating activities from continuing operations was $60 million. Free cash flow was a use of cash of $90 million for the second quarter 2026 compared to a source of cash of $55 million in the prior year period.On June 16,
More news about: Huntsman Corporation
Jul 30, 2026, 16:15 ET Dolby Laboratories Reports Third Quarter 2026 Financial Results
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash(1,881)
More news about: Dolby Laboratories, Inc.
Jul 30, 2026, 16:15 ET Arthur J. Gallagher & Co. Announces Second Quarter 2026 Financial Results
Dec 31, 2025Cash and cash equivalents$ 1,386
More news about: Arthur J. Gallagher & Co.
Jul 30, 2026, 16:15 ET Invesco Mortgage Capital Inc. Reports Second Quarter 2026 Financial Results
6,276,609Cash and cash equivalents73,381
More news about: Invesco Mortgage Capital Inc.
Jul 30, 2026, 16:15 ET Erie Indemnity Reports Second Quarter 2026 Results
Cash and cash equivalents (includes restricted cash of $39,608 and $30,189, respectively)
More news about: Erie Indemnity Company
Jul 30, 2026, 16:15 ET CNO Financial Group Reports Second Quarter 2026 Results
programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from company-owned life insurance ("COLI") and alternative investment income not allocated to product lines), net of interest
More news about: CNO Financial Group
Jul 30, 2026, 16:08 ET AMH Reports Second Quarter 2026 Financial and Operating Results
and Retained Cash Flow are not substitutes for net income or net cash provided by operating activities, each as determined in accordance with GAAP, as a measure of our operating performance, liquidity or ability to pay dividends. These metrics also are not necessarily indicative of cash available to
More news about: AMH
Jul 30, 2026, 16:06 ET Karyopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway
agreement and the potential future financial implications of such agreement; Karyopharm's ability to enroll patients in its clinical trials; unplanned cash requirements and expenditures; substantial doubt exists regarding Karyopharm's ability to continue as a going concern; development or regulatory approval
More news about: Karyopharm Therapeutics Inc.
Jul 30, 2026, 16:05 ET Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
reconciliations.Capital expenditures for free cash flow purposes were $39 million for Q2 2026. Cash flow provided by operations was $201 million, compared to $234 million in the prior year period. Free cash flow (cash flow provided by operations less capital expenditures) was $162 million
More news about: Illumina, Inc.
Jul 30, 2026, 16:05 ET GRAND CANYON EDUCATION, INC. REPORTS SECOND QUARTER 2026 RESULTS
Our liquidity position, as measured by cash and cash equivalents and investments decreased by $25.6 million between December 31, 2025 and June 30, 2026, which was largely attributable to cash expended for share repurchases and capital expenditures exceeding our cash provided by operations during the six
More news about: Grand Canyon Education, Inc.
Jul 30, 2026, 16:05 ET Castle Biosciences Reports Second Quarter 2026 Results
in 2025.Net cash used in operations was $6.9 million, compared to $14.8 million net cash provided by operations for the same period in 2025.Cash, Cash Equivalents and Marketable Investment SecuritiesAs of Jun. 30, 2026, the Company's cash, cash equivalents and marketable
More news about: Castle Biosciences, Inc.
Jul 30, 2026, 16:05 ET Olin Announces Second Quarter 2026 Results
Cash and Cash Equivalents$
More news about: Olin Corporation
Jul 30, 2026, 16:05 ET DIAMONDROCK HOSPITALITY COMPANY REPORTS SECOND QUARTER 2026 RESULTS
the following items:Non-Cash Lease Expense and Other Amortization: We exclude the non-cash expense incurred from the straight line recognition of expense from our ground leases and other contractual obligations and the non-cash amortization of our favorable and unfavorable contracts,
More news about: DiamondRock Hospitality Company
Jul 30, 2026, 16:05 ET Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Cash and cash equivalents
More news about: Penumbra, Inc.
Jul 30, 2026, 16:05 ET Socket Mobile Reports Second Quarter 2026 Results
quarter.Operating loss amounted to $1,195,000, compared to a $677,000 loss in the prior year's quarter, and a loss of $760,000 in the preceding quarter.Cash balance as of June 30, 2026, was approximately $1.6 million, slightly lower from $1.7 million at March 31, 2026."Our second-quarter results
More news about: Socket Mobile, Inc.
Jul 30, 2026, 16:05 ET Farmer Mac Reports Second Quarter 2026 Results
Cash and cash equivalents (includes restricted cash of $26,984 and $24,475, respectively)$ 1,038,091
More news about: Farmer Mac
Jul 30, 2026, 16:05 ET PEOPLES FINANCIAL SERVICES CORP. Reports Unaudited Second Quarter and Year to Date 2026 Earnings
higher yielding US agency mortgage-backed securities and tax-exempt bonds. The Company used the remaining proceeds and the majority of the principal cash flows received during the first half of 2026 to fund loan growth. Held to maturity ("HTM") securities totaled $68.7 million at June 30, 2026, a decrease
More news about: Peoples Financial Services Corp.
Jul 30, 2026, 16:05 ET Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer
agreement and the potential future financial implications of such agreement; Karyopharm's ability to enroll patients in its clinical trials; unplanned cash requirements and expenditures; substantial doubt exists regarding Karyopharm's ability to continue as a going concern; development or regulatory approval
More news about: Karyopharm Therapeutics Inc.
Jul 30, 2026, 16:01 ET STANDEX REPORTS FISCAL FOURTH QUARTER AND FISCAL YEAR 2026 FINANCIAL RESULTS
million at the end of fiscal fourth quarter 2025. Net (cash) debt for the fourth quarter of 2026 consisted primarily of long-term debt of $518.0 million and cash and equivalents of $178.7 million.Cash Flow: Net cash provided by continuing operating activities for the
More news about: Standex International Corporation
Jul 30, 2026, 16:01 ET PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
expenses were $88.6 million for the second quarter of 2026, excluding $10.5 million in non-cash, stock-based compensation expense, compared to $104.0 million for the second quarter of 2025, excluding $9.0 million in non-cash, stock-based compensation expense.GAAP SG&A expenses were $80.6 million
More news about: PTC Therapeutics, Inc.
Jul 30, 2026, 16:01 ET Neurocrine Biosciences Reports Second-Quarter 2026 Financial Results
2025Total Cash, Cash Equivalents, and Marketable Securities$ 482
More news about: Neurocrine Biosciences, Inc.